Reactive oxygen species in the initiation of IL-4 driven autoimmunity as a potential therapeutic target
As reflected in the evolving strategies of food manufacturers and the food service industry, there is a growing recognition of the need to adapt product offerings to support individuals experiencing medication-induced appetite suppression
Recent statistics show that obesity is especially a concern in the United States
Drawing on both clinical expertise and personal insights, McCall outlines the potential consequences of under-treatment, including mental health decline, metabolic issues, and autoimmune progression
As such, it appears that COVID-19 (and other viral infectious diseases) is accompanied by three different inflammatory phases: (a) beneficial protective inflammation, which combats the infection and may mount a restorative repair, (b) hyperinflammation, which may lead to a cytokine storm and critical disease or even death, and (c) non-resolving inflammation resulting in a protracted mild inflammatory state [105] as observed in Long COVID
50 , D543D552 (2022)
